136 related articles for article (PubMed ID: 34560382)
1. The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines.
Yaseen MM; Abuharfeil NM; Darmani H
Cell Immunol; 2021 Nov; 369():104440. PubMed ID: 34560382
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.
Silva de Castro I; Gordon SN; Liu J; Bissa M; McKinnon K; Trinh HV; Doster MN; Schifanella L; Liyanage NP; Cao J; Cheng O; Foulds K; Roederer M; Koup RA; Shen X; Tomaras GD; Venzon DJ; Forthal DN; Fouts T; Montefiori DC; Tartaglia J; Rao M; Ostrowski M; Franchini G; Vaccari M
J Virol; 2020 Feb; 94(6):. PubMed ID: 31896599
[TBL] [Abstract][Full Text] [Related]
3. Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response
Liu L; Lin Q; Peng J; Fang J; Tan Z; Tang H; Kwan K; Nishiura K; Liang J; Kwok H; Du Z; Sun J; Liu K; Yuen KY; Wang H; Chen Z
EBioMedicine; 2020 Oct; 60():103008. PubMed ID: 32979832
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection.
Yaseen MM; Abuharfeil NM; Darmani H
Open Biol; 2021 Nov; 11(11):210216. PubMed ID: 34753323
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.
Sui Y; Frey B; Wang Y; Billeskov R; Kulkarni S; McKinnon K; Rourke T; Fritts L; Miller CJ; Berzofsky JA
PLoS Pathog; 2017 May; 13(5):e1006395. PubMed ID: 28498847
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.
Zhang R; Zhang S; Li M; Chen C; Yao Q
Vaccine; 2010 Jul; 28(31):5114-27. PubMed ID: 20471443
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Myeloid-Derived Suppressor Cells in Human Immunodeficiency Virus-1/ Hepatitis C Virus-coinfected Patients.
Lei AH; Yang Q; Cai WP; Liu YF; Lan Y; Qin AP; Hu FY; Zhou J
Scand J Immunol; 2016 Jun; 83(6):438-44. PubMed ID: 26972443
[TBL] [Abstract][Full Text] [Related]
9. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
[TBL] [Abstract][Full Text] [Related]
10. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
[TBL] [Abstract][Full Text] [Related]
11. Anatomical Distribution of Myeloid-Derived Suppressor Cells During HIV Infection.
Yaseen MM; Abuharfeil NM; Darmani H
Viral Immunol; 2021 Dec; 34(10):673-678. PubMed ID: 34851737
[TBL] [Abstract][Full Text] [Related]
12. MDSC expansion during HIV infection: regulators, ART and immune reconstitution.
Yaseen MM; Abuharfeil NM; Darmani H
Genes Immun; 2024 Jun; 25(3):242-253. PubMed ID: 38605259
[TBL] [Abstract][Full Text] [Related]
13. The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.
Yao WR; Li D; Yu L; Wang FJ; Xing H; Yang GB
Immunol Res; 2017 Aug; 65(4):869-879. PubMed ID: 28478499
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Derived Suppressor Cells Associated With Disease Progression in Primary HIV Infection: PD-L1 Blockade Attenuates Inhibition.
Zhang ZN; Yi N; Zhang TW; Zhang LL; Wu X; Liu M; Fu YJ; He SJ; Jiang YJ; Ding HB; Chu ZX; Shang H
J Acquir Immune Defic Syndr; 2017 Oct; 76(2):200-208. PubMed ID: 28570288
[TBL] [Abstract][Full Text] [Related]
15. Determining the immune mechanisms of protection from AIDS: correlates of immunity and the development of syngeneic macaques.
Kent SJ; Ada GL; Hayes E; Lewis IM
Immunol Rev; 2001 Oct; 183():94-108. PubMed ID: 11782250
[TBL] [Abstract][Full Text] [Related]
16. HIV vaccines: Unmasking myeloid derived suppressor cells.
Green WR; O'Connor MA
EBioMedicine; 2020 Nov; 61():103063. PubMed ID: 33038766
[No Abstract] [Full Text] [Related]
17. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
[TBL] [Abstract][Full Text] [Related]
18. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
Schwerdtfeger M; Andersson AC; Neukirch L; Holst PJ
J Transl Med; 2019 May; 17(1):175. PubMed ID: 31126293
[TBL] [Abstract][Full Text] [Related]
19. Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against
Gamba JC; Roldán C; Prochetto E; Lupi G; Bontempi I; Poncini CV; Vermeulen M; Pérez AR; Marcipar I; Cabrera G
Front Cell Infect Microbiol; 2021; 11():671104. PubMed ID: 34295832
[No Abstract] [Full Text] [Related]
20. CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.
Liu J; Yu Q; Stone GW; Yue FY; Ngai N; Jones RB; Kornbluth RS; Ostrowski MA
Vaccine; 2008 Jul; 26(32):4062-72. PubMed ID: 18562053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]